Skip to main content
HR 2352 107th Congress House Taxation Business income tax Commerce Consumer education Costs Deceptive advertising Drug advertising Drug industry Drugs Government Operations and Politics Government paperwork Health Income tax Tax deductions

Fair Balance Prescription Drug Advertisement Act of 2001

Introduced: June 27, 2001 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 107th Congress ended
It never became law before the 107th Congress (2001–2002) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 16, 2001
Referred to the Subcommittee on Health, for a period to be subsequently determined by the Chairman.
Jun 27, 2001
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 27, 2001
Sponsor introductory remarks on measure. (CR E1225-1226)
Jun 27, 2001
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service
Fair Balance Prescription Drug Advertisement Act of 2001 - Amends the Internal Revenue Code and the Federal Food, Drug, and Cosmetic Act (FDCA) to prohibit a deduction for any expense of an advertisement for a prescription drug if, with respect to such advertisement, the Secretary of Health and Human Services has submitted to the Secretary of the Treasury a report with respect to direct-to-consumer advertising that certain FDCA misbranding violations have occurred.
What's happening now July 16, 2001

Referred to the Subcommittee on Health, for a period to be subsequently determined by the Chairman.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 3
 Cosponsors 2
All 2 Democratic 2
D
Pallone, Frank
New Jersey · May 21, 2002
 D
Norton, Eleanor Holmes
District of Columbia · Oct 4, 2001
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2352: Fair Balance Prescription Drug Advertisement Act of 2001. 107th Congress. Open America. https://openamerica.io/bill/107-HR-2352/
MLA
"H.R. 2352: Fair Balance Prescription Drug Advertisement Act of 2001." 107th Congress, 2026, Open America, https://openamerica.io/bill/107-HR-2352/.
Bluebook (legal)
H.R. 2352, 107th Cong. (2026), https://openamerica.io/bill/107-HR-2352/.
Markdown link
[H.R. 2352: Fair Balance Prescription Drug Advertisement Act of 2001](https://openamerica.io/bill/107-HR-2352/)
Report a problem